Cat. No. | Product name | CAS No. |
DC3162 |
Eszopiclone
Eszopiclone is a nonbenzodiazepine hypnotic which is slightly effective for insomnia. |
138729-47-2 |
DC7770 |
Etamicastat
Etamicastat is a novel dopamine β-hydroxylase inhibitor |
760173-05-5 |
DC21003 |
ETC-206
Featured
ETC-206 (ETC-1907206) is a novel potent, selective MNK1/2 inhibitor with IC50 of 64/86 nM, inhibits eIF4E phosphorylation inhibition in HeLa cell line with IC50 of 321 nM. |
1464151-33-4 |
DC8123 |
ETH 157(Sodium ionophore II)
Featured
ETH 157(Sodium ionophore II)is a neutral ionophore for liquid-membrane electrodes of high selectivity for Na+. |
61595-77-5 |
DCAPI1235 |
Ethionamide
Ethionamide |
536-33-4 |
DC10267 |
Ethosuximide
Ethosuximide is a succinimide anticonvulsant, used mainly in absence seizures. |
77-67-8 |
DC12182 |
Ethyl docosa-4,7,10,13,16,19-hexaenoate
Ethyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is enriched in the ethyl ester fraction by the selective alcoholysis of fatty acid ethyl esters originating from tuna oil with lauryl alcohol. |
84494-72-4 |
DC10046 |
Etizolam
Featured
Etizolam(AHR3219; Y7131) is a benzodiazepine analog. |
40054-69-1 |
DC7411 |
Etofenamate
Featured
Etofenamate is a non-steroidal anti-inflammatory drug used for the treatment joint and muscular pain. |
30544-47-9 |
DC7124 |
ETP-46464
Featured
ETP-46464 is a cell-permeable quinoline-containing heterotricyclic compound that acts as a potent inhibitor against mTOR, ATR, DNA-PK, PI 3-Kα, and ATM (IC50= 0.6, 14, 36, 170, and 545 nM, respectively). |
1345675-02-6 |
DC9884 |
Etretinate
Etretinate is an oral aromatic retinoid acid which is effective in psoriasis and other dermatological syndromes. |
54350-48-0 |
DC20376 |
Etriciguat
Etriciguat is a novel potent, selective, orally available soluble guanylate cyclase (sGC) stimulator.. |
402595-29-3 |
DC8870 |
Eupatilin
Featured
Eupatilin is a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells. |
22368-21-4 |
DC12061 |
Eurycomanone
Eurycomanone could increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis. |
84633-29-4 |
DC7125 |
Evacetrapib (LY2484595)
Featured
Evacetrapib (LY2484595) is a potent and selective inhibitor of CETP with IC50 of 5.5 nM, elevates HDL cholesterol without increases in aldosterone or blood pressure. |
1186486-62-3 |
DC7126 |
QNZ(EVP4593)
Featured
EVP4593 is a derivative of 6-aminoquinazoline class that has been previously isolated as an inhibitor of PMA/PHA-induced NF-κB pathway activation in Jurkat cells (IC50= 9 nM). |
545380-34-5 |
DC7578 |
Exatecan (Mesylate)
Featured
Exatecan mesylate is a semisynthetic, water-soluble derivative of camptothecin with antineoplastic activity. |
169869-90-3 |
DC21005 |
EXEL-0346
EXEL-0346 (EXEL0346) is a novel potent, orally active Glucosylceramide synthase (GCS) inhibitor with IC50 of 2 nM. |
1239893-96-9 |
DC8260 |
Exemestane(FCE 24304)
Featured
Exemestane(FCE 24304) is an aromatase inhibitor, inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM, respectively. |
107868-30-4 |
DC22518 |
Exenatide
Exenatide (Exendin-4) is a 39-aa peptide, highly potent, long-acting glucagon-like peptide-1 receptor (GLP-1) agonist with IC50 of 3.22 nM. |
141758-74-9 |
DC22517 |
Exendin-4 acetate
Featured
Exenatide acetate (Exendin-4 acetate) is the acetate of Exenatide, which is highly potent, long-acting glucagon-like peptide-1 receptor (GLP-1) agonist with IC50 of 3.22 nM.. |
914454-01-6 |
DC9532 |
ADH-1 trifluoroacetate
Featured
Exherin (ADH-1) trifluoroacetate is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities; selectively and competitively binds to and blocks N-cadherin. |
1135237-88-5 |
DC10905 |
Exo1
Featured
Exo1 is a cell-permeable, reversible inhibitor of exocytosis (IC50 = 20 µM). |
75541-83-2 |
DC7204 |
Ezatiostat(TER199; TLK199)
Featured
Ezatiostat(TER199; TLK199) is a glutathione analog inhibitor of glutathione S-transferase (GST) P1-1. |
168682-53-9 |
DC20377 |
EZH2-IN-3
EZH2-IN-3 is a highly selective small molecule inhibitor of EZH2 and EZH1 with IC50 of 21/197/213 nM for wt EZH2/EZH2 Y641N/wt EZH1 respectively. |
1377997-28-8 |
DC9821 |
Ezutromid
Featured
Ezutromid is a novel Small utrophin's translation modulator with EC50 of 0.4 uM . |
945531-77-1 |
DC20379 |
Factor D inhibitor 6
Factor D inhibitor 6 is a potent and selective, orally bioavailable inhibitor of Factor D with IC50 of 30 nM. |
1386455-51-1 |
DC23545 |
Factor D inhibitor 7
Factor D inhibitor 7 is a potent and selective, orally bioavailable inhibitor of Factor D with IC50 of 50 nM. |
1386455-76-0 |
DC21899 |
Fadaltran
Fadaltran is a α2-adrenoreceptor antagonist.. |
1799809-36-1 |
DC21900 |
FAK inhibitor 5
FAK inhibitor 5 is the first highly potent, selective irreversible inhibitor of the FAK kinase with IC50 of 0.6 nM. |
2237234-47-6 |
DCAPI1576 |
Falecalcitriol
Falecalcitriol |
83805-11-2 |
DC21650 |
Famitinib
Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor, including c-Kit, VEGFR2/3, PDGFRβ, FLT-1/3 receptor and c-RET. |
945380-27-8 |
DC10910 |
Fantofarone
Featured
Fantofarone is a calcium channel blocker. |
114432-13-2 |
DC20380 |
Faropenem
Faropenem is an orally active beta-lactam antibiotic with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes. |
106560-14-9 |
DC24118 |
C75
Featured
C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM). |
218137-86-1 |
DC20381 |
Fasentin
Featured
Fasentin is a novel inhibitor of glucose uptake (GLUT) that sensitizes cancer cells to FAS-induced cell death, preferentially inhibits GLUT4 (IC50=68 uM) over GLUT1. |
392721-37-8 |
DC22759 |
FAS-IN-1
FAS-IN-1 is a potent inhibitor of fatty acid synthase (FAS) wtih IC50 of 10 nM.. |
1375105-96-6 |
DC10403 |
FAS-IN-1 Tosylate
FAS-IN-1 tosylate is a potent inhibitor of fatty acid synthase (FAS) extracted from patent WO 2012064642 A1, compound 29; has an IC50 of 10 nM. |
|
DC10213 |
Fatostatin
Featured
Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2. |
298197-04-3 |
DC23119 |
FB23-2(FTO Demethylase inhibitor FB23-2)
Featured
FB23-2 is a potent, selective inhibitor of the mRNA N 6-methyladenosine (m 6A) demethylase FTO, directly bind to FTO, inhibits FTO demethylation of m6 A in RNA in vitro with IC50 of 2.6 uM. |
2243736-45-8 |
DC23507 |
FC131
Featured
FC131 (cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)) is a selective, cyclopentapeptide CXCR4 antagonist with IC50 of 126 nM, exhibits anti-HIV activity in assays using NL4-3 and IIIB strains with EC50 of 21 nM.. |
606968-52-9 |
DC9753 |
FCCP
Featured
FCCP is a very potent uncoupler of oxidative phosphorylation in mitochondria,that disrupts ATP synthesis by transporting protons across cell membranes. |
370-86-5 |
DC23678 |
FCPR03
FCPR03 is a novel potent, selective PDE4 inhibitor with IC50 of 60, 31 and 47 nM for PDE4CAT (PDE4 catalytic domain), PDE4B1 and PDE4D7, respectively. |
1917347-65-9 |
DC25015 |
FD-44
FD-44 (FD44, NCS-1-Ric8a inhibitor FD44) is a potent inhibitor of the NCS-1/Ric8a interaction, interferes with NCS-1/Ric8a binding, and restores normal synapse number and associative learning in a Drosophila FXS model. |
68207-21-6 |
DC26037 |
FDL-169
Featured
FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector being developed by Flatley Discovery Lab for treating cystic fibrosis (CF) patients who carry the F508del mutation |
1628416-28-3 |
DCAPI1591 |
FEBUXOSTAT
Featured
FEBUXOSTAT is an inhibitor xanthine oxidase and xanthine dehydrogenase |
144060-53-7 |
DC5099 |
Felbamate
Featured
Felbamate (Felbatol) is an anticonvulsant drug used in the treatment of epilepsy. |
25451-15-4 |
DC9105 |
Felodipine
Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker. |
72509-76-3 |
DC20382 |
FEN1-IN-1
FEN1-IN-1 is a potent, selective Flap Endonuclease-1 (FEN1) inhibitor with IC50 of 11 nM. |
824983-91-7 |
DC20383 |
FEN1-IN-C20
FEN1-IN-C20 is an N‐hydroxyl urea derivative that specifically inhibits flap endonuclease 1 (FEN1) activity with IC50 of 3 nM. |
824983-94-0 |
DCAPI1181 |
Fenbendazole (Panacur)
Fenbendazole (Panacur) |
43210-67-9 |
DC9065 |
Fenofibric acid
Fenofibric acid is a lipid regulating agent available as delayed release capsules for oral administration. |
42017-89-0 |
DC9424 |
Fenoldopam (mesylate)
Featured
Fenoldopam(SKF 82526) mesylate is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. |
67227-57-0 |
DCAPI1157 |
Fenoprofen calcium
Fenoprofen calcium |
34597-40-5 |
DC8684 |
Fenoxaprop-P-ethyl
Featured
Fenoxaprop-P-ethyl is a post-emergent phenoxy herbicide of the aryloxyphenoxy propionate group. |
71283-80-2 |
DCAPI1326 |
Fenticonazole nitrate
Fenticonazole nitrate |
73151-29-8 |
DC12246 |
Feretoside
Feretoside, a phenolic compound extracted from the barks of E. ulmoides, is a HSP inducer which act as cytoprotective agent. |
27530-67-2 |
DC20102 |
Ferulic acid methyl ester
Featured
Ferulic acid methyl ester (Methyl ferulate) is a derivative of ferulic acid, isolated from Stemona tuberosa, with anti-inflammatory and antioxidant properties. Ferulic acid methyl ester is a cell membrane and brain permeable compound, shows free radical s |
2309-07-1 |
DC23516 |
Fesoterodine
Fesoterodine (PF-00695838) is a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. |
286930-02-7 |
DC23515 |
Fesoterodine maleate
Fesoterodine (PF-00695838) is a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. |
250214-44-9 |
DC7811 |
Fexinidazole
Featured
Fexinidazole is a new Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness |
59729-37-2 |
DC21010 |
FF-10501-01
FF-10501-01 is a potent, selective and orally available IMPDH inhibitor. |
56973-26-3 |
DC10973 |
FF-10502
FF-10502 (FF-10502-01) is a pyrimidine nucleoside antimetabolite that shows growth inhibition of pancreatic cancer cell lines with IC50 of 60-330 nM. |
184302-49-6 |
DC23627 |
FFN-206 dihydrochloride
FFN-206 is an excellent VMAT2 (vesicular monoamine transporter 2) substrate capable of detecting VMAT2 activity in intact cells using fluorescence microscopy, with subcellular localization to VMAT2-expressing acidic compartments without apparent labeling |
1883548-88-6 |
DC21012 |
FGI-103
FGI-103 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67). |
907169-69-1 |
DC21013 |
FGI-104
FGI-104 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67). |
|
DC7637 |
FH1(BRD-K4477)
Featured
FH1 (BRD-K4477) is a small molecule, which promotes differentiation of iPS-derived hepatocytes. |
2719-05-3 |
DC20384 |
Fhit-IN-15
Fhit-IN-15 is a potent, competitive, reversible inhibitor of the enzymatic activity of tumor suppressor Fhit with IC50 of 49 nM, shows cytotoxicity in HEK293T cells.. |
683784-49-8 |
DC20385 |
FICZ
Featured
FICZ is a high affinity aryl hydrocarbon receptor (AhR) agonist with Kd of 70 pM. |
172922-91-7 |
DC21673 |
Fidarestat
Fidarestat (SNK860) is a potent aldose reductase inhibitor, improves motor nerve conduction velocity (MNCV) and metabolic abnormalities in sciatic nerve were investigated in acute STZ-induced diabetic rats.. |
136087-85-9 |
DC21817 |
Filaminast
Filaminast (WAY-PDA-641. |
141184-34-1 |
DC21482 |
Filibuvir
Filibuvir (PF-00868554. |
877130-28-4 |
DC9349 |
Fimasartan
Featured
Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure. |
247257-48-3 |
DC11432 |
FimH inhibitor 5h
FimH inhibitor 5h is a potent and orally active FimH inhibitor. |
2240179-36-4 |
DC23501 |
Finazine
Finazine is a high-affinity, brain penetrant sigma-1 and sigma 2 receptor ligand with Ki of 2.6 nM and 46 nM, respectively. |
441745-52-4 |
DC12637 |
Finerenone
Featured
Finerenone (BAY 94-8862) is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold). Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease. |
1050477-31-0 |
DC8200 |
Firategrast(SB-683699)
Featured
Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS). |
402567-16-2 |
DC21015 |
FIT-039
Featured
FIT-039 is a potent, selective CDK9 inhibitor with IC50 of 5.8 uM for CKD9/cyclin T1, suppresses the replication of HSV-1 (IC50=0.69 uM). |
1113044-49-7 |
DC9845 |
FITM
Featured
FITM is a nove mGlu1 inhibitor. FITM shows high affinity (Ki = 2.5 nM, fig. S2) and selectivity for mGlu1 over mGlu5. |
932737-65-0 |
DC20386 |
Pioglitazone
Featured
Pioglitazone is a potent and selective PPARγ agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively. |
111025-46-8 |
DC21016 |
FJ 5002
FJ 5002 is a potent telomerase inhibitor with IC50 of 2 uM, a close derivative of MKT077. |
247129-77-7 |
DC22093 |
FKGK18
FKGK18 (FKGK18) is a potent, selective inhibitor of iPLA2 (group VIA Ca2+-independent phospholipase A2) with IC50 of 50 nM. |
1071001-09-6 |
DC20019 |
Flagelin 22(TFA) (Flagellin 22(TFA))
Flagelin 22 TFA, a fragment of bacterial flagellin, is an effective elicitor in both plants and algae. |
|
DC11414 |
Flavoxate Hydrochloride
Featured
Flavoxate Hydrochloride(DW-61 Hydrochloride) is a muscarinic AChR antagonist used in various urinary syndromes and as an antispasmodic. |
3717-88-2 |
DCAPI1347 |
Fleroxacin (Quinodis)
Fleroxacin (Quinodis) |
79660-72-3 |
DC7415 |
FLI-06
Featured
FLI-06 is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2.3 μM). |
313967-18-9 |
DC9321 |
Flibanserin
Featured
Flibanserin is a novel multifunctional serotonin agonist and antagonist (MSAA) that improves sexual functioning in premenopausal women who suffer from reduced sexual interest and desire. |
167933-07-5 |
DC8230 |
FLT3-IN-1(SKLB4771)
Featured
FLT3-IN-1(SKLB4771) is a novel potent and selective Flt3 inhibitor with IC50 of 10 nM; against FLT3-ITD-expressing MV4-11 cells with IC50 of 6 nM. |
1370256-78-2 |
DC9060 |
Flubendazole
Flubendazole is a potent broad spectrum anthelmintic. |
31430-15-6 |
DCAPI1375 |
Fluconazole
Fluconazole |
86386-73-4 |
DCAPI1108 |
Flucytosine (Ancobon)
Flucytosine (5-Fluorocytosine, 5-FC, Ancobon) is an antifungal drug with IC50 of 0.12 μg/mL in C.albicans. |
2022-85-7 |
DC5889 |
Fludarabine
Featured
Fludarabine (Synonyms: F-ara-A; NSC 118218) is a prodrug converted to free nucleoside 9-β-D-arabinosyl-2-fluoroadenine (F-ara-A). F-ara-A enters cells and accumulates as 5’-triphosphate. Interferes with DNA synthesis and repair. |
21679-14-1 |
DC4190 |
Fludarabine phosphate
Featured
Fludarabine Phosphate is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis. |
75607-67-9 |
DC8337 |
Fluensulfone
Featured
Fluensulfone is a new nematicide of the fluoroalkenyl thioether group that has significantly reduced environmental impact with low toxicity to non-target insects and mammals. |
318290-98-1 |
DC11413 |
Flumatinib
Featured
Flumatinib is a multi-kinase inhibitor with IC50 Values of 1.2 nM, 307.6 nM and 2662 nM for c-Abl, PDGFRβ and c-Kit respectively. |
895519-90-1 |
DCAPI1180 |
Flumequine
Flumequine |
42835-25-6 |
DC8910 |
Flunarizine dihydrochloride
Featured
Flunarizine is a selective calcium entry blocker. |
30484-77-6 |
DCAPI1301 |
Fluocinolone acetonide (Flucort-N)
Fluocinolone acetonide (Flucort-N) |
67-73-2 |
DCAPI1161 |
Fluocinonide(Vanos)
Fluocinonide(Vanos) |
356-12-7 |
DC22475 |
FITC
Featured
Fluorescein isothiocyanate(FITC) is a derivative of fluorescein used in wide-ranging applications including flow cytometry. |
3326-32-7 |
DC10424 |
Fluorescein-5-maleimide
Featured
Fluorescein-5-maleimide is a fluorescent thiol-reactive dye used to conjugate fluorescein to proteins (excitation: 494 nm, emission: 519 nm). |
75350-46-8 |
DC9669 |
Fluoroclebopride
Featured
Fluoroclebopride is useful chemical for PET image study. |
154540-49-5 |
DC10238 |
Fluoxymesterone
Fluoxymesterone is an Androgen. The mechanism of action of fluoxymesterone is as an Androgen Receptor Agonist. |
76-43-7 |
DC12247 |
Fluspirilene (R 6218; Redeptin)
Featured
Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia. |
1841-19-6 |
DC10020 |
Fluticasone furoate
Featured
Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. |
397864-44-7 |
DC10678 |
Fluticasone
Featured
Fluticasone is a synthetic glucocorticoid which is used in some countries to treat nasal symptoms. |
90566-53-3 |
DCAPI1353 |
Fluticasone propionate (Flonase, Veramyst)
Fluticasone propionate (Flonase, Veramyst) |
80474-14-2 |
DCAPI1585 |
Fluyastatin Sodium Salt
Fluvastatin, Sodium Salt is a synthetic inhibitor of HMGCR (HMG-CoA reductase) (IC50 = 40-100 nM for human liver microsomes) that acts as an anti-hypercholesterolemic compound and as an antioxidant. Fluvastatin also inhibits induction of the LDL receptor |
93957-55-2 |
DC9139 |
Fluvoxamine maleate
Fluvoxamine maleate is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. |
61718-82-9 |
DC22228 |
Fluzoparib
Featured
Fluzoparib (SHR 3162) is a selective poly [ADP-ribose] polymerase 1 (PARP1) and poly [ADP-ribose] polymerase 2 inhibitor (PARP2), being developed by Jiangsu HengRui Medicine, for the treatment of cancer. PARP enzymes play a vital role in repair of DNA dam |
1358715-18-0 |
DC26027 |
FMF-04-159-2
Featured
FMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively. |
2364489-81-4 |
DC21018 |
FN075
FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation. |
864405-82-3 |
DC21019 |
FOBISIN 101
Featured
FOBISIN 101 is a small molecule 14-3-3 protein-protein interaction inhibitor with IC50 of 9.3 and 16.4 uM for the binding of 14-3-3ζ or 14-3-3γ to PRAS40, respectively. |
1370281-06-3 |
DC10252 |
Fomepizole
Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. |
7554-65-6 |
DC4207 |
Fondaparinux sodium
Featured
Fondaparinux sodium is a synthetic and specific inhibitor of activated Factor X (Xa). |
114870-03-0 |
DCAPI1249 |
Acesulfame Potassium
Featured
Acesulfame potassium is an artificial sweetener. Acesulfame potassium (long-term) affects cognitive functions, potentially via altering neuro-metabolic functions in mice. |
55589-62-3 |
DC8285 |
Acotiamide HCl
Featured
Acotiamide monohydrochloride trihydrate is an orally active and first-in-class gastroprokinetic agent for the treatment of functional dyspepsia. Acotiamide monohydrochloride trihydrate enhances acetylcholine released by enteric neurons through muscarinic |
773092-05-0 |
DC8204 |
AS2034178,
For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, Please contact DC Chemicals.. |
1030846-42-4 |
DC7870 |
BBS-4
For the detailed information of BBS-4, the solubility of BBS-4 in water, the solubility of BBS-4 in DMSO, the solubility of BBS-4 in PBS buffer, the animal experiment (test) of BBS-4, the cell expriment (test) of BBS-4, the in vivo, in vitro and clinical trial test of BBS-4, the EC50, IC50,and affinity,of BBS-4, Please contact DC Chemicals.. |
402934-09-2 |
DCAPI1114 |
Betamethasone valerate (Betnovate)
For the detailed information of Betamethasone valerate (Betnovate), the solubility of Betamethasone valerate (Betnovate) in water, the solubility of Betamethasone valerate (Betnovate) in DMSO, the solubility of Betamethasone valerate (Betnovate) in PBS buffer, the animal experiment(test) (test) of Betamethasone valerate (Betnovate), the cell expriment (test) of Betamethasone valerate (Betnovate), the in vivo, in vitro and clinical trial test of Betamethasone valerate (Betnovate), the EC50, IC50,and Affinity of Betamethasone valerate (Betnovate),, please contact DC Chemicals.. |
2152-44-5 |
DC8046 |
BIO-32546
For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, Please contact DC Chemicals.. |
1548743-66-3 |
DCAPI1083 |
Dimesna
For the detailed information of Dimesna, the solubility of Dimesna in water, the solubility of Dimesna in DMSO, the solubility of Dimesna in PBS buffer, the animal experiment(test) (test) of Dimesna, the cell expriment (test) of Dimesna, the in vivo, in vitro and clinical trial test of Dimesna, the EC50, IC50,and Affinity of Dimesna,, please contact DC Chemicals.. |
16208-51-8 |
DC7849 |
DTP3
Featured
For the detailed information of DTP3, the solubility of DTP3 in water, the solubility of DTP3 in DMSO, the solubility of DTP3 in PBS buffer, the animal experiment (test) of DTP3, the cell expriment (test) of DTP3, the in vivo, in vitro and clinical trial test of DTP3, the EC50, IC50,and affinity,of DTP3, Please contact DC Chemicals.. |
1809784-29-9 |
DC7013 |
Epothilone F
For the detailed information of Epothilone F, the solubility of Epothilone F in water, the solubility of Epothilone F in DMSO, the solubility of Epothilone F in PBS buffer, the animal experiment (test) of Epothilone F, the cell expriment (test) of Epothilone F, the in vivo, in vitro and clinical trial test of Epothilone F, the EC50, IC50,and Affinity of Epothilone F, Please contact DC Chemicals.. |
208518-52-9 |
DC8367 |
IN00076730
For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, Please contact DC Chemicals.. |
1454700-89-0 |
DC7017 |
KF-4317
For the detailed information of KF-4317, the solubility of KF-4317 in water, the solubility of KF-4317 in DMSO, the solubility of KF-4317 in PBS buffer, the animal experiment (test) of KF-4317, the cell expriment (test) of KF-4317, the in vivo, in vitro and clinical trial test of KF-4317, the EC50, IC50,and Affinity of KF-4317, Please contact DC Chemicals.. |
76805-48-6 |
DC7546 |
LHW090-A7
Featured
For the detailed information of LHW090-A7, the solubility of LHW090-A7 in water, the solubility of LHW090-A7 in DMSO, the solubility of LHW090-A7 in PBS buffer, the animal experiment (test) of LHW090-A7, the cell expriment (test) of LHW090-A7, the in viv |
1308256-94-1 |
DC7580 |
Naxagolide
Featured
For the detailed information of Naxagolide, the solubility of Naxagolide in water, the solubility of Naxagolide in DMSO, the solubility of Naxagolide in PBS buffer, the animal experiment (test) of Naxagolide, the cell expriment (test) of Naxagolide, the in vivo, in vitro and clinical trial test of Naxagolide, the EC50, IC50,and Affinity of Naxagolide, Please contact DC Chemicals.. |
88058-88-2 |
DC7618 |
NI-(S)-BPB-GLY
Featured
For the detailed information of NI-(S)-BPB-GLY, the solubility of NI-(S)-BPB-GLY in water, the solubility of NI-(S)-BPB-GLY in DMSO, the solubility of NI-(S)-BPB-GLY in PBS buffer, the animal experiment (test) of NI-(S)-BPB-GLY, the cell expriment (test) of NI-(S)-BPB-GLY, the in vivo, in vitro and clinical trial test of NI-(S)-BPB-GLY, the EC50, IC50,and Affinity of NI-(S)-BPB-GLY, Please contact DC Chemicals.. |
96293-19-5 |
DC8441 |
Nitenpyram
Featured
Nitenpyram is a chemical frequently used as an insecticide in agriculture and veterinary medicine. The compound is an insect neurotoxin belonging to the class of neonicotinoids which works by blocking neural signaling of the central nervous system. |
150824-47-8 |
DC5110 |
NSC157100
For the detailed information of NSC157100, the solubility of NSC157100 in water, the solubility of NSC157100 in DMSO, the solubility of NSC157100 in PBS buffer, the animal experiment (test) of NSC157100, the cell expriment (test) of NSC157100, the in vivo, in vitro and clinical trial test of NSC157100, the EC50, IC50,and Affinity of NSC157100, Please contact DC Chemicals.. |
39204-49-4 |
DC7022 |
NSC17711
For the detailed information of NSC17711, the solubility of NSC17711 in water, the solubility of NSC17711 in DMSO, the solubility of NSC17711 in PBS buffer, the animal experiment (test) of NSC17711, the cell expriment (test) of NSC17711, the in vivo, in vitro and clinical trial test of NSC17711, the EC50, IC50,and Affinity of NSC17711, Please contact DC Chemicals.. |
1112-24-9 |
DC7024 |
Ospemifene
For the detailed information of Ospemifene, the solubility of Ospemifene in water, the solubility of Ospemifene in DMSO, the solubility of Ospemifene in PBS buffer, the animal experiment (test) of Ospemifene, the cell expriment (test) of Ospemifene, the in vivo, in vitro and clinical trial test of Ospemifene, the EC50, IC50,and Affinity of Ospemifene, Please contact DC Chemicals.. |
128607-22-7 |
DC7025 |
PB30239
For the detailed information of PB30239, the solubility of PB30239 in water, the solubility of PB30239 in DMSO, the solubility of PB30239 in PBS buffer, the animal experiment (test) of PB30239, the cell expriment (test) of PB30239, the in vivo, in vitro and clinical trial test of PB30239, the EC50, IC50,and Affinity of PB30239, Please contact DC Chemicals.. |
1251012-82-4 |
DC7551 |
RG3039(PF-06687859)
Featured
For the detailed information of PF-0668759, the solubility of PF-0668759 in water, the solubility of PF-0668759 in DMSO, the solubility of PF-0668759 in PBS buffer, the animal experiment (test) of PF-0668759, the cell expriment (test) of PF-0668759, the |
1005504-62-0 |
DC6915 |
Phenothrin
For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, Please contact DC Chemicals.. |
26002-80-2 |
DC22285 |
praeruptorin B
Featured
For the detailed information of praeruptorin B, the solubility of praeruptorin B in water, the solubility of praeruptorin B in DMSO, the solubility of praeruptorin B in PBS buffer, the animal experiment(test) (test) of praeruptorin B, the cell expriment (test) of praeruptorin B, the in vivo, in vitro and clinical trial test of praeruptorin B, the EC50, IC50,and Affinity of praeruptorin B,, please contact DC Chemicals.. |
73069-28-0 |
DC7844 |
PST2286
For the detailed information of PST2286, the solubility of PST2286 in water, the solubility of PST2286 in DMSO, the solubility of PST2286 in PBS buffer, the animal experiment (test) of PST2286, the cell expriment (test) of PST2286, the in vivo, in vitro and clinical trial test of PST2286, the EC50, IC50,and affinity,of PST2286, Please contact DC Chemicals.. |
26629-41-4 |
DCAPI1402 |
Reboxetine mesylate
For the detailed information of Reboxetine mesylate, the solubility of Reboxetine mesylate in water, the solubility of Reboxetine mesylate in DMSO, the solubility of Reboxetine mesylate in PBS buffer, the animal experiment(test) (test) of Reboxetine mesylate, the cell expriment (test) of Reboxetine mesylate, the in vivo, in vitro and clinical trial test of Reboxetine mesylate, the EC50, IC50,and Affinity of Reboxetine mesylate,, please contact DC Chemicals.. |
98769-84-7 |
DC7616 |
RO 15-3890
Featured
For the detailed information of RO 15-3890, the solubility of RO 15-3890 in water, the solubility of RO 15-3890 in DMSO, the solubility of RO 15-3890 in PBS buffer, the animal experiment (test) of RO 15-3890, the cell expriment (test) of RO 15-3890, the in vivo, in vitro and clinical trial test of RO 15-3890, the EC50, IC50,and Affinity of RO 15-3890, Please contact DC Chemicals.. |
84378-44-9 |
DC8209 |
SD-70
Featured
A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM). |
332173-89-4 |
DC8210 |
SKP2-C25
For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, Please contact DC Chemicals.. |
|
DC7507 |
HIV-1 integrase inhibitor 8
Featured
HIV-1 integrase inhibitor 8 is a HIV-1 integrase inhibitor, compound 8[1]. |
1568-80-5 |
DC7032 |
SR03168
For the detailed information of SR03168, the solubility of SR03168 in water, the solubility of SR03168 in DMSO, the solubility of SR03168 in PBS buffer, the animal experiment (test) of SR03168, the cell expriment (test) of SR03168, the in vivo, in vitro and clinical trial test of SR03168, the EC50, IC50,and Affinity of SR03168, Please contact DC Chemicals.. |
484654-44-6 |
DC7033 |
SR03298A
For the detailed information of SR03298A, the solubility of SR03298A in water, the solubility of SR03298A in DMSO, the solubility of SR03298A in PBS buffer, the animal experiment (test) of SR03298A, the cell expriment (test) of SR03298A, the in vivo, in vitro and clinical trial test of SR03298A, the EC50, IC50,and Affinity of SR03298A, Please contact DC Chemicals.. |
805250-17-3 |
DC8211 |
SR10067
For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, Please contact DC Chemicals.. |
1380548-02-6 |
DCAPI1260 |
Sulfamethazine
For the detailed information of Sulfamethazine, the solubility of Sulfamethazine in water, the solubility of Sulfamethazine in DMSO, the solubility of Sulfamethazine in PBS buffer, the animal experiment(test) (test) of Sulfamethazine, the cell expriment (test) of Sulfamethazine, the in vivo, in vitro and clinical trial test of Sulfamethazine, the EC50, IC50,and Affinity of Sulfamethazine,, please contact DC Chemicals.. |
57-68-1 |
DC7973 |
Tenovin-2
Featured
For the detailed information of Tenovin-2, the solubility of Tenovin-2 in water, the solubility of Tenovin-2 in DMSO, the solubility of Tenovin-2 in PBS buffer, the animal experiment (test) of Tenovin-2, the cell expriment (test) of Tenovin-2, the in vivo, in vitro and clinical trial test of Tenovin-2, the EC50, IC50,and affinity,of Tenovin-2, Please contact DC Chemicals.. |
666211-30-9 |
DC7974 |
Tenovin-5
For the detailed information of Tenovin-5, the solubility of Tenovin-5 in water, the solubility of Tenovin-5 in DMSO, the solubility of Tenovin-5 in PBS buffer, the animal experiment (test) of Tenovin-5, the cell expriment (test) of Tenovin-5, the in vivo, in vitro and clinical trial test of Tenovin-5, the EC50, IC50,and affinity,of Tenovin-5, Please contact DC Chemicals.. |
688014-33-7 |
DC8176 |
Tradipitant(VLY-686)
Featured
For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), Please contact DC Chemicals.. |
622370-35-8 |
DC6916 |
Zucapsaicin
For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, Please contact DC Chemicals.. |
25775-90-0 |
DC9045 |
Formestane
Formestane(CGP-32349; 4-OHA) is a selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer. |
566-48-3 |
DC1017 |
Forskolin
Featured
Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC). |
66575-29-9 |
DC10181 |
Forsythoside B
Forsythoside B is a phenylethanoid glycoside isolated from the leaves of Lamiophlomis rotata Kudo, a Chinese folk medicinal plant for treating inflammatory diseases and promoting blood circulation. |
81525-13-5 |
DC21472 |
Fosdagrocorat
Fosdagrocorat (PF 04171327) is an orally available, potential dissociated agonist of the glucocorticoid receptor (GR) for the treatment of rheumatoid arthritis, the phosphate ester prodrug of PF-00251802 (dagrocorat).. |
1044535-58-1 |
DC11086 |
Foslinanib
Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation. |
1256037-60-1 |
DC12068 |
Fosmidomycin sodium salt
Featured
Fosmidomycin sodium salt is a phosphonic acid antibiotic and a antimalarial drug, which is active against both Gram-negative and Gram-positive bacteria. |
66508-37-0 |
DC12063 |
Fosravuconazole
Fosravuconazole is a prodrug of ravuconazole, with antifungal activity. |
351227-64-0 |
DC23114 |
R788 disodium hexahydrate
Featured
Fostamatinib (R788) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM. |
914295-16-2 |
DC12315 |
Fosteabine (Cytarabine ocfosfate; YNK 01)
Fosteabine is an oral and prodrug analogue of cytarabine which is resistant to deoxycytidine deaminase. |
73532-83-9 |
DC10510 |
FPH1 (BRD-6125)
Featured
FPH1 (BRD-6125) is a small molecule, which promotes expansion of iPS-derived hepatocytes. |
708219-39-0 |
DC8720 |
FPS-ZM1
Featured
FPS-ZM1 is a blood-brain-barrier permeant blocker of RAGE V domain-mediated ligand binding (Ki = 25, 148, & 230 nM, respectively. |
945714-67-0 |
DC21023 |
FQI1
FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 2.1 uM. |
599151-35-6 |
DC21024 |
FQI2
FQI2 is a small-molecule inhibitor of transcription factor LSF with IC50 of 0.71 uM. |
1373209-41-6 |
DC21025 |
FR900098 sodium salt
Featured
FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively.. |
73226-73-0 |
DC12242 |
FR194738
FR194738 is a squalene epoxidase inhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8 nM. |
204067-52-7 |
DC12398 |
FR58P1a
FR58P1a is a mitochondrial metabolism-affecting compound that uncouples OXPHOS through a protonophoric mechanism, selectively inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway. |
|
DC23729 |
FR-901464
Featured
FR-901464 is a potent antitumor natural product that binds to the splicing factor 3b (SF3b) complex and inhibits pre-mRNA splicing, inhibits cell cycle progression at G1 and G2/M phases.. |
146478-72-0 |
DC8631 |
Framycetin sulphate
Framycetin sulphate |
4146-30-9 |
DC8003 |
FRAX-486
Featured
FRAX486 is a selective inhibitor of group I PAKs with IC50s of 8.25/39.5, /55.3 nM for PAK1/PAK2/PAK3 respectivelt; less potent for PAK4(IC50=779 nM). |
1232030-35-1 |
DCQ-033 |
fraxin
Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity. |
524-30-1 |
DC23050 |
fraxinellone
Featured
Fraxinellone is a selective blocker of voltage-dependent Ca2+ channel, which possesses antimicrobial, anti-inflammatory, neuroprotective and vasorelaxing activities. |
28808-62-0 |
DC9344 |
Frentizole
Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction. |
26130-02-9 |
DC20208 |
Frovatriptan Succinate
Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity especially for the 5-HT1B/1D receptors. |
158930-09-7 |
DC21026 |
FSC 231
FSC 231 (FSC231) is the first, cell-permeable small-molecule inhibitor of PICK1 PDZ domain with Kd of 10.1 uM. |
1215849-96-9 |
DC23388 |
FT-001
FT-001 is a novel potent, orally acitve inhibitor of BET bromodomain with IC50 of 0.1 uM for BRD4 BD1. |
1778655-51-8 |
DC20272 |
FT113
Featured
FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. |
1630808-89-7 |
DC22096 |
FT895
FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM, displays no significant activity against HDAC1-10 (IC50>5 uM). |
2225728-57-2 |
DC11029 |
FTBMT
Featured
FTBMT is a novel selective GPR52 agonist of GPR52, increases intracellular cAMP levels in CHO cells expressing human, mouse, or rat GPR52, with pEC50 of 7.03, 6.85, and 6.87M, respectively. |
1358575-02-6 |
DC12537 |
FtsZ inhibitor C109
FtsZ inhibitor C109 (Compound 10126109) is a broad spectrum antibacterial compound that inhibits the cell division protein FtsZ, inhibits the FtsZ GTPase activity with IC50 of 8.2 uM. |
|
DC12362 |
Fuchsine base monohydrochloride
Fuchsine base (monohydrochloride) is a magenta dye, which is certified for use for acid-fast staining with carbol-fuchsin. |
632-99-5 |
DCAPI1052 |
Fudosteine
Fudosteine |
13189-98-5 |
DC11394 |
Fulacimstat(BAY 1142524)
Featured
Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor. |
1488354-15-9 |
DC4200 |
Fulvestrant
Featured
Fulvestrant is an estrogen receptor (ER) antagonist with IC50 of 0.094 nM. |
129453-61-8 |
DC8855 |
Fumagillin
Featured
Fumagillin is a selective and potent irreversible inhibitor of Methionine aminopeptidase 2 (MetAP2), used as an antibiotic to treat microsporidiosis. |
23110-15-8 |
DCAPI1020 |
Fumalic acid (Ferulic acid)
Featured
Fumalic acid (Ferulic acid) |
1135-24-6 |
DC21027 |
Fumosorinone
Fumosorinone is a novel potent, selective protein tyrosine phosphatase SHP2 inhibitor with IC50 of 6.31 uM. |
1879030-70-2 |
DC9069 |
Furosemide
Furosemide (Lasix) is a loop diuretic inhibitor of Na+/2Cl-/K+ (NKCC) cotransporter of which used in the treatment of congestive heart failure and edema. |
54-31-9 |
DC10240 |
Fusidate Sodium
Fusidate Sodium is a sodium salt form of fusidic acid, a bacteriostatic antibiotic derived from the fungus Fusidium coccineum and used as a topical medication to treat skin infections. |
751-94-0 |
DC21792 |
FV-100
FV-100 (Valnivudine, CF-1743) is a potent, selective, bicyclic nucleoside analogue inhibitor of varicella zoster virus (VZV) with EC50 of subnanomolar range in vitro.. |
956483-03-7 |
DC21031 |
FzM1.8
FzM1.8 is a small molecule, allosteric agonist of the Frizzled receptor Fzd4 with pEC50 of 6.4, potentiates β-catenin pathway in the absence of any WNT ligand. |
2204290-85-5 |
DC21032 |
G 0507
G 0507 is a novel inhibitor of the bacterial LolCDE ABC transporter, binds to LolCDE and stimulates its ATPase activity. |
1223998-29-5 |
DC21034 |
G 573
G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM. |
22868-35-5 |
DC11449 |
G0775
G0775 is a Synethetic analogs of arylomycins. |
2098663-92-2 |
DC24027 |
STING Agonist-1(G-10)
Featured
G10 (STING Agonist 1) is a novel human-specific STING agonist. |
702662-50-8 |
DC12300 |
G3-C12 TFA
G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (Kd) of 88 nM, but shows no affinity for other galectin family members or to other lectins. |
|
DC22548 |
G-5555
G-5555 is a potent and selective PAK1 inhibitor (Ki=3.7 nM). |
1648863-90-4 |
DC12438 |
G6PD activator AG1
Featured
G6PD activator AG1 (AG1) is a specific, small molecule that increases the activity of the wild-type, Canton mutant (R459L, EC50=3 uM) and several other common G6PD mutants; displays no effect on the dimerization or activity of several other NAD- or NADP+-dependent dimeric or tetrameric enzymes, including 6PGD, GAPDH, ALDH2, and ALDH3A1; attenuates ROS-induced pericardial edema in a G6PD-dependent manner in zebrafish, reduces hemolysis of human erythrocytes |
421581-52-4 |
DC21035 |
G907
G907 is a potent, selective small-molecule antagonist of ATP-binding cassette (ABC) transporter MsbA with IC50 of 18 nM. |
|
DC21036 |
E-72
G9a inhibitor E72 (E-72) is a potent inhibitor of histone H3K9 methyltransferases G9a and G9a-like protein (GLP) with Kd of 136 nM and 164 nM, shows selectivity over the related H3K9 methyltransferase Suv39H2. |
1435055-73-4 |